ch. 15 Flashcards

1
Q

In asthma the bronchi are hyperactive to stimuli increasing the production of…

A

Immunoglobulin E(IgE), mast cell degranulation and inflammatory-mediators.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Most common spirometry tests used to diagnose and manage asthma?

A

FVC(forced viral capacity) FEV1 and FEV1/ FEV%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Reversibility or indicator of airway responsiveness to bronchodilator is defined as?

A

Increase in FEV1 and FVC of 12%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What additional tests are used to differentiate asthma from childhood diseases?

A

Broncoprovocation challenge, chest radiograph, allergy testing, sputum, blood and urine testing.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What test uses methacholine or mannitol inhalation to induce hyperactivity of small airways to see a reduction in FEV1

A

Broncoprovocation challenge test

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What % of reduction of FEV1 is considered positive for the broncoprovocation test?

A

20% reduction of FEV1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Exercise tolerance tests are performed over 5 to 8 minutes and heart rate is increased to 85% of predicted. What decline % of FEV1 shows a positive response?

A

Decline of 15% of FEV1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Exercise test is more or less sensitive to bronchial hyper responsiveness?

A

Less sensitive

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Asthma expert panel report(EPR-3) divides asthma assessment and treatment into how many ranges?

A

3: 0-4 years, 5-11 years, 12 years or older.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Asthma is categorized into two domains, which are?

A

Impairment and risk

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Four classifications of asthma

A

Intermittent, mild persistent, moderate persistent, and severe.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Impairment for intermittent asthma

A

Symptoms<2 days a week, 0 night time awakenings, Saba for symptoms _< 2 days a week, no interference with normal activity. 0-1 exacerbations requiring oral steroids.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Mild persistent asthma classification

A

> 2 days/week but not daily
Nighttime awakenings 1-2 times a month.
Saba for symptoms > 2 days a week but not daily.
Interference with normal activity- minor
exacerbations in 6 months requiring oral steroids or 4 wheezing episodes per year.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Moderate persistent asthma classification

A
Symptoms daily
Nighttime awakenings- 3-4 times a month
Saba for symptoms daily
Some limitation to normal activity
> 2 exacerbations in 6 months requiring oral steroids or 4 wheezing episodes per year.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Sever asthma classification

A

Symptoms: throughout the day

Nighttime awakenings: > 1 time a week

Saba for symptoms: several times per day

Extremely limited activity

> 2 exacerbations in 6 months requiring oral steroids or 4 wheezing episodes per year

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Detailed history and physical is useful in

A

Differentiating asthma from other diseases.

17
Q

Decrease pharmacological therapy if asthma control improves and sustains for

A

3 months

18
Q

What is the key element for asthma home management?

A

Education

19
Q

Peak flow monitor is not as sensitive as the FEV1 to changes in?

A

Diameter of small airways.

20
Q

Used to measure how much air can move out of the airway with a blast of exhalation.

A

Peak flow meter

21
Q

Step 1 asthma

A

Saba prn

22
Q

Step 2 asthma

A

Low dose ics can use chromolyn or montelukast

23
Q

Step 3 asthma

A

Medium dose ics

24
Q

Step 4 asthma

A

Medium dose ics+ LABA or montelukast

25
Q

Step 6 asthma control

A

High dose ics+ LABA or montelukast

Oral steroids

26
Q

Managements of asthma 4 components

A

components:
(1)Assess and monitor asthma severity and control
(2)Partner with patients and families to educate them on their asthma plan of care
(3)Control environmental factors and comorbid conditions that trigger asthma exacerbation
(4)Prescribe appropriate medications for treatment of asthma
–Assess and monitor asthma severity and control

27
Q

Quick relief rescue

A

–SABAs
–3–5 minutes onset
–4–6 hours effect
–Normally not on a regular basis

28
Q

Asthma management in the hospital

A

•Poor response to therapy within the first few hours of treatment (2–4) in the ED or a repeat visit within 24 hours of discharge home from the ED

29
Q

Cystic Fibrosis

A
  • Life-limiting autosomal recessive disorder

* Affects approximately 80,000 individuals worldwide

30
Q

Etiology CF

A

–Single gene defect on chromosome 7
–Carriers have few or no symptoms.
–Each child conceived from two CF carriers has a 25% chance of being affected with CF, a 50% of being a carrier

31
Q

Loss of cftr

A

have a profound impact on water and electrolyte transport across the epithelium.

32
Q

CFTR is a chloride channel expressed in the

A

Apical membrane of epithelial cells of lung, pancreas, sweat duct, reproductive, kidney, liver, sub mucosal glands

33
Q

Newborn screening tests for CF

A

IRT imunoreactive trypsinogen

Sweat chloride test- 75 mg of sweat collected over 30 mins

34
Q

A sweat chloride test of more than what Suggests CF

A

60 mmol/L on two occasions